March 21, 2026 | Kobe, Japan
The 1st JSRM–ISCT Joint Symposium on iPS Cell-Based Regenerative Medicine will bring together experts from academia, clinical practice, regulatory bodies, and industry to discuss the future of iPS cell–based therapies. The program will explore key challenges and opportunities across translational research, clinical development, regulation, and commercialization, providing a platform for international dialogue and collaboration to advance regenerative medicine.
Imec will host a luncheon seminar during the event. Dr. Olivier Henry will present on “Enabling process automation and analytics integration in regenerative and cell therapy manufacturing,” focusing on how advanced technologies can support scalable manufacturing for regenerative and cell therapies.
Session details:
The 1st JSRM–ISCT Joint Symposium on iPS Cell-Based Regenerative Medicine will bring together experts from academia, clinical practice, regulatory bodies, and industry to discuss the future of iPS cell–based therapies. The program will explore key challenges and opportunities across translational research, clinical development, regulation, and commercialization, providing a platform for international dialogue and collaboration to advance regenerative medicine.